Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. (SHE:300452)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Medicine Manufacturing	942.40M	882.29M	838.96M	704.18M	616.38M
Medicine Manufacturing Growth	6.81%	5.16%	19.14%	14.25%	16.11%
Site Lease Income	395.94K	286.85K	303.87K	342.51K	331.66K
Site Lease Income Growth	38.03%	-5.60%	-11.28%	3.27%	-1.13%
Total	942.80M	882.57M	839.26M	704.53M	616.71M
Total Growth	6.82%	5.16%	19.12%	14.24%	16.10%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
East China	359.79M	343.11M	308.72M	264.34M	237.56M
East China Growth	4.86%	11.14%	16.79%	11.28%	23.01%
Southern China	99.03M	117.44M	111.46M	82.03M	75.41M
Southern China Growth	-15.68%	5.36%	35.89%	8.78%	-12.71%
North China, Northeast Region	136.17M	112.17M	147.91M	132.47M	113.13M
North China, Northeast Region Growth	21.40%	-24.17%	11.66%	17.09%	22.56%
Central China	87.50M	95.09M	85.23M	71.53M	73.91M
Central China Growth	-7.98%	11.58%	19.14%	-3.21%	21.26%
Southwest and Northwest Region	76.12M	73.54M	85.18M	59.51M	53.17M
Southwest and Northwest Region Growth	3.51%	-13.67%	43.13%	11.92%	33.44%
Overseas	184.19M	141.22M	100.76M	94.64M	63.54M
Overseas Growth	30.42%	40.16%	6.46%	48.96%	8.43%
Total	942.80M	882.57M	839.26M	704.53M	616.71M
Total Growth	6.82%	5.16%	19.12%	14.24%	16.10%

Source: S&P Global Market Intelligence.